AP1S1, a part of the adaptor protein complex involved in clathrin-mediated endocytosis, is highly expressed in breast cancer and glioblastoma and is associated with poor prognosis (Zheng et al., 2022; Wu et al., 2022). Here, AP1S1 is linked to breast carcinoma.